Index Entries

Johnson & Johnson clinical trial: A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants

https://clinicaltrials.gov/ct2/show/NCT04505722 

First posted August 10, 2020; last update May 6, 2023
National Library of Medicine
Janssen Vaccines & Prevention B.V.

“Actual Study Completion Date: March 31, 2023”

document
clinical trials,COVID-19,FDA approvals,manufacturers,vaccines